This study proves the crucial role of fractalkine in bone tumors, consistent with the previous finding that the fractalkine/CX3CR1 axis plays a crucial role in the bone microenvironment of multiple myeloma metastasis [41]. The gene discussed is CX3CL1; the disease is plasma cell myeloma.